Publications by authors named "Marc Earl"

Claim this Profile
L
Leveraging advanced preparation of oncology medications: Decreasing turnaround-times in an outpatient infusion center.
James Blackmer, Kevin Amoline, Jacqueline Amancher, Eric Vogan, Heather Zimmer, Marc Earl

J Oncol Pharm Pract· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of IV oncology infusions compounded via robotics and gravimetrics-assisted workflow processes.
Bob Pang, Marc Earl, Scott Knoer, Angela Yaniv, Marc Willner

Am J Health Syst Pharm· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Descriptive comparison of hospital formulary decisions with published oncology valuation methods.
Simon W Lam, Caitlin Siebenaller, Marc Earl, Brian T Hill, Matt Kalaycio

J Oncol Pharm Pract· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an operational productivity tool within a cancer treatment center pharmacy.
Thomas S Achey, Allison R Riffle, Robert M Rose, Marc Earl

Am J Health Syst Pharm· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASHP-HOPA guidelines on the roles and responsibilities of the pharmacy technician in ambulatory oncology pharmacy.
Jason Bergsbaken, Danielle Roman, Marc A Earl, Ali McBride, Jacqueline L Olin

Am J Health Syst Pharm· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer.
Simon W Lam, Maya Wai, Jessica E Lau, Michael McNamara, Marc Earl

Pharmacotherapy· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review in the treatment of oncologic emergencies.
Judy Pi, Young Kang, Michael Smith, Marc Earl, Zaven Norigian

J Oncol Pharm Pract· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of Inappropriate Prophylactic Pegylated Granulocyte Colony-Stimulating Factor Use for Patients With Non-Small-Cell Lung Cancer Who Receive Chemotherapy: An ASCO Quality Training Program Project of the Cleveland Clinic Taussig Cancer Institute.
Lindsey Martin Goodman, Machelle B Moeller, Abdel-Ghani Azzouqa, Amy E Guthrie, Carole K Dalby, Marc A Earl

J Oncol Pract· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing Time to Antibiotic Administration for Febrile Neutropenia in the Emergency Department.
Michael K Keng, Elaine A Thallner, Paul Elson, Christine Ajon, Jennifer Sekeres, Marc A Earl

J Oncol Pract· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromes.
Yogen Saunthararajah, Mikkael Sekeres, Anjali Advani, Reda Mahfouz, Lisa Durkin, Marc Earl

J Clin Invest· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of atropine-diphenoxylate compared with hyoscyamine to decrease rates of irinotecan-related cholinergic syndrome.
Connie Cheng, Jessica E Lau, Marc A Earl

J Community Support Oncol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rates of febrile neutropenia with pegfilgrastim on same day versus next day of CHOP with or without rituximab.
Connie Cheng, Erika M Gallagher, Jun-Yen Yeh, Marc A Earl

Anticancer Drugs· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight.
Candice M Wenzell, Erika M Gallagher, Marc Earl, Jun-Yen Yeh, Karissa N Kusick

Am J Hematol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia.
Di Sun, Paul Elson, Michaela Liedtke, Bruno C Medeiros, Marc Earl

Am J Hematol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Race and intensity of post-remission therapy in acute myeloid leukemia.
Anna K Brady, Alex Z Fu, Marc Earl, Matt Kalaycio, Anjali Advani

Leuk Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia.
Marc Earl

Clin Adv Hematol Oncol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis